@Framatome_

💚𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 On World Cancer Day, let's honor the courage of those living with cancer and Oncia Community supporting them. 💙 #WorldCancerDay #UnitedByUnique #Cancer #OnciaCommunity #CancerCare

👥 Meet us at #𝗔𝗿𝗮𝗯𝗛𝗲𝗮𝗹𝘁𝗵2025 at booth S1.F10! Meet our leading experts who are ready to discuss your radioisotopes' needs and provide you with insights into the latest innovations with custom-designed cyclotrons and integrated solutions. @Arab_Health

RT @AP_MedTechZone: #Cancercare gets a boost as 1st Cyclotron in #AndhraPradesh gets #AERB license to start commercial production and suppl…

🔬 Trends in Nuclear Medicine with Prof Dr Rudi Dierckx. Navigate through the evolving landscape, from significant advancements to growing interest of pharmaceutical industry. 🎥 Missed previous episodes? Let’s shape the future of healthcare together 💚

🌟 We are heading to Arab Health 2025! Are you attending #ArabHealth2025 from January 27 to 30 in Dubaï? Join us at booth S1.F10 and let's engage in meaningful conversations about your needs. Discover our tailor-made #radiopharmaceutical production solutions designed for you.

🎬Webinar | Targeted Alpha Therapy: Navigating the Path to Clinical Implementation and Future Outlook 🤵Prof Dr Levillain, @JulesBordet & Prof Dr Giesel, @UniklinikDUS 📅January 27 👉Register now: #Webinar #NuclearMedicine #TAT #Astatine211 #Actinium225

🚀Curious about our vision for 2025? Watch the interview with our Head of R&D department and discover the developments we are bringing to life, from #radiochemistry to targeted alpha therapies.🎬 Missed the first episode with Prof Dr Rudi Dierckx? 👉

🔬 Exciting Times for Nuclear Medicine in 2025, our new series with Prof Dr Rudi Dierckx, globally renowned expert in the field! Follow our account and don't miss out on the next capsules! Let’s shape the future of healthcare together 💚 #NuclearMedicine #Radiopharmaceuticals

RT @CalaisJeremie: Low- and High-Volume Disease in mHSPC: from CHAARTED to #PSMA PET #stagemigration @UnterrainerL…

RT @DrMHofman: SPECT deserves RESPECT! @drlouiseemmett makes the argument that it is a powerful tool for theranostics ➤ enabling early,…

🎬 Join us for our exclusive webinar on targeted alpha therapy with renowned experts, Prof Dr Frederik Giesel from @UniklinikDUS and Prof Dr @LevillainHugo1 from @JulesBordet. Register now👉  #Astatine211 #Actinium225 #IBAcommunity

RT @BioWin_asbl: IRE strengthens its leadership in radiopharmaceutical production with the arrival of the 30 MeV IBA cyclotron at its site.…

RT @TelixPharma: Telix has completed the installation of two new cyclotrons at Telix Manufacturing Solutions (TMS) in Brussels South, Belgi…

📣Breaking News Almathera selected IBA to equip its first private radiopharmacy and theranostics complex with Cyclone® KIUBE 300 in Kazakhstan. Read the Press Release 👉

RT @Accelerate_Eu: We pioneer the development of novel radiotheranostic pairs featuring the alpha-emitting isotope #astatine-211 to target…

🔎𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝘄𝗲 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗲𝗱 𝗼𝘂𝗿 𝗞𝗮𝗿𝗲 𝗣𝗼𝗿𝘁𝗮𝗹? Watch the video of Cedric Jacques, our Customer Service Director, who shares his insights. 📨 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝘆𝗼𝘂𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝗻𝗼𝘄:

📢You asked for it. We delivered. Discover our new customer portal and unlock your potential with your cyclotron, anytime, anywhere. Reach incomparable efficiency in your operations using our unique online platform to access real-time services. 👉

Breaking News 📢 IBA and Jules Bordet Institute will lead IHI project to create complete Astatine-211 value chain. Read our Press Release👉 Don't miss the next updates about this project @Accelerate_Eu #IBA #Astatine @JulesBordet